Investors

Copyright Nasdaq. Minimum 15 minutes delayed.

SEC Filings

Filing date Description Form Filing Group Issuer View

40FR12B

40FR12B
Other
Immunovaccine Inc. View HTML

40FR12B/A

40FR12B/A
Other
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

EFFECT

EFFECT
Other
Immunovaccine Inc. View HTML